Key result
Among ICD patients, a paced QRS notch duration ≥50 ms was associated with lower antitachycardia pacing effectiveness and a higher risk of shocks.
Why the study?
Does a duration of a notch ≥0.1 mV in the paced QRS complex ≥ 50 milliseconds predict lower antitachycardia pacing effectiveness in ICD patients with left ventricular dysfunction?
Cohort (n=286)
Does a duration of a notch ≥0.1 mV in the paced QRS complex ≥ 50 milliseconds predict lower antitachycardia pacing effectiveness in ICD patients with left ventricular dysfunction?
Answers are grounded in this paper and cite their sources.
A notch duration ≥ 50 milliseconds in the paced QRS complex is a useful ECG marker for predicting lower antitachycardia pacing effectiveness and a higher risk of shocks in ICD patients.
INTRODUCTION: The presence of notches in the paced QRS complex (P-QRS) from the right ventricular apex (RVA) reflects delays in the activation of the left ventricle and may therefore be associated with longer times of stimulus conduction. Our objective was to determine prospectively the relationship between the duration of a notch ≥0.1 mV in the P-QRS (DN) and the effectiveness of antitachycardia pacing (ATP). METHODS AND RESULTS: We followed 286 implantable cardioverter-defibrillator (ICD) patients with left ventricular dysfunction (pacing site: RVA) for 41 ± 27 months. ICD programming was standardized. P-QRS (100 bpm) was obtained at implant (50 mm/s). A total of 955 monomorphic ventricular tachycardias (VTs) with a cycle length of 335 ± 32 milliseconds occurred consecutively in 108 patients. ATP was successful in 84% of VTs. DN correlated with the probability of ineffective ATP (C = 0.67; P < 0.001), the cutoff point with the best sensitivity and specificity being 50 milliseconds. The adjusted mean ATP effectiveness per patient was 76% (95% CI: 72-85). Patients with a DN ≥ 50 milliseconds had a lower ATP efficiency: 67% (56-77) versus 92% (87-97) and a higher proportion of VTs terminated with shocks (SH): 31% (21-42) versus 8% (2-14); P < 0.001 for both. Although the occurrence of VT was similar (41% vs. 40%), the incidence of VT-related SH was higher in patients with a DN ≥ 50 (25% vs. 14%; P = 0.01) in the overall study population (n = 286). CONCLUSIONS: When ATP is applied to the RVA, a DN ≥ 50 milliseconds is associated with a lower ATP effectiveness and a higher risk of SH due to VT.
No takes yet. Share an insight, caveat, or question.
Jiménez‐Candil et al. (2014) conducted a cohort in Left ventricular dysfunction with an implantable cardioverter-defibrillator (n=286). Duration of a notch ≥0.1 mV in the paced QRS complex ≥ 50 milliseconds vs. Duration of a notch < 50 milliseconds was evaluated on Antitachycardia pacing (ATP) effectiveness (p=<0.001). Among ICD patients, a paced QRS notch duration ≥50 ms was associated with lower antitachycardia pacing effectiveness and a higher risk of shocks.
Synapse has enriched 10 related papers. Consider them for comparative context: